Insider Transactions in Q1 2022 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
200
-1.18%
|
$62,800
$314.36 P/Share
|
|
Mar 08
2022
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
591
-2.81%
|
$183,801
$311.0 P/Share
|
|
Mar 07
2022
|
Joseph M Zubretsky President & CEO |
SELL
Bona fide gift
|
Direct |
1,600
-0.62%
|
-
|
|
Mar 04
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.8%
|
$1,575,000
$315.0 P/Share
|
|
Mar 01
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,205
-10.45%
|
$3,173,755
$311.88 P/Share
|
|
Mar 01
2022
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,152
+17.56%
|
$6,889,272
$311.88 P/Share
|
|
Mar 01
2022
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-7.06%
|
$331,837
$311.88 P/Share
|
|
Mar 01
2022
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,370
+18.61%
|
$1,048,070
$311.88 P/Share
|
|
Mar 01
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,990
-6.72%
|
$3,728,890
$311.88 P/Share
|
|
Mar 01
2022
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,869
+9.87%
|
$6,490,259
$311.88 P/Share
|
|
Mar 01
2022
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,861
-12.92%
|
$22,659,771
$311.88 P/Share
|
|
Mar 01
2022
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,956
+17.35%
|
$41,038,316
$311.88 P/Share
|
|
Mar 01
2022
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,548
-6.64%
|
$2,658,428
$311.88 P/Share
|
|
Mar 01
2022
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,510
+13.62%
|
$6,689,610
$311.88 P/Share
|
|
Mar 01
2022
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-3.16%
|
$194,686
$311.88 P/Share
|
|
Mar 01
2022
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
3,527
+15.11%
|
$1,096,897
$311.88 P/Share
|
|
Feb 23
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
105
-0.62%
|
$32,235
$307.97 P/Share
|
|
Feb 22
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
195
-1.13%
|
$61,035
$313.21 P/Share
|
|
Jan 10
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,325
-3.66%
|
$382,925
$289.7 P/Share
|
|
Jan 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+1.0%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+1.15%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+1.79%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+0.82%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+4.52%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+3.39%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+3.91%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+19.39%
|
$55,014
$318.08 P/Share
|